I de tolv kontrollerede forsøg var infektionshyppigheden 1, 49 pr. patientår hos Trudexa- behandlede patienter og 1, 42 pr. patientår hos placebo - og aktiv kontrolbehandlede patienter.
ed In the twelve controlled trials, the rate of infection was 1.49 per patient year in the Trudexa treated patients and 1.42 per patient year in the placebo and active control-treated patients.